Preclinical Investigation of Artesunate as a Therapeutic Agent for Hepatocellular Carcinoma via Impairment of Glucosylceramidase-Mediated Autophagic Degradation

0
168
Experiments revealed an association between autophagic activity and glucosylceramidase expression in clinical HCC samples, tumor tissues from a rat model of inflammation-induced HCC, an orthotopic mouse model, and human HCC cell lines.
[Experimental and Molecular Medicine]
Full Article